이상반응 보고
| VAERS ID | 2576472 |
|---|---|
| 성별 | 여성 |
| 나이 | 66세 |
| 주 코드 | |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | EW0175 |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-05-05 |
| 발병일 | 2022-12-26 |
| 상태 | 입원 사망 |
증상
- 호흡곤란(Dyspnoea)
- 졸음(Somnolence)
- 기침(Cough)
- 인플루엔자(Influenza)
- 코로나 바이러스 감염증 -19 : 코로나 19(COVID-19)
- 심방 세동(Atrial fibrillation)
- 기관 삽관(Endotracheal intubation)
- 심초음파 정상(Echocardiogram normal)
- 죽음(Death)
- 뇌병증(Encephalopathy)
- 사출 비율 정상(Ejection fraction normal)
- 충격(Shock)
- 급성 호흡 부전(Acute respiratory failure)
- 패혈성 쇼크(Septic shock)
- 급성 호흡기 장애 증후군(Acute respiratory distress syndrome)
- 염증 마커 증가(Inflammatory marker increased)
- 중복 감염(Superinfection)
- 폐렴 세균(Pneumonia bacterial)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Patient is a 68 y.
o.
female with PMHx of focal epilepsy, SCC of lung, COPD (stage IV), HTN, fibromyalgia presenting with SOB and cough.
Assessment and Plan Acute hypoxic respiratory failure with ARDS d/t COVID-19/influenza co-infection w probable superimposed bacterial PNA COPD, not in exacerbation Hx of SCC of R lung Shock Acute encephalopathy with somnolence Hx of focal epilepsy pAF with RVR vs MAT Likely septic shock from coinfection with COVID/influenza and possible superimposed bacterial PNA with ARDS.
Remains intubated On high-dose pressors On Tamiflu, Remdesivir, stress dose Decadron Bronchodilators Inflammatory markers elevated 2D echo with EF 70%, grossly unremarkable Aztreonam/doxycycline Palliative care following On IV keppra Therapeutic Lovenox Discussed with critical care Prognosis very poor Discussed with the family at bedside; in keeping with goals of care vasopressors discontinued.
Patient peacefully expired today at 8:55 AM in the presence of family.
Psychological emotional support provided